Table 3

Policy and planning recommendations and goals

Stakeholder levelPolicy optionGoals
Challenge 1: Weak data systems and evidence for political prioritisation and public awareness
 NationalFormal inclusion of childhood cancer in national NCD policy and planning, for example, broadened scope of inclusion of childhood cancer in National Cancer Control StrategyCatalyse opportunities for greater health system prioritisation of childhood cancer
 National InstitutionalDevelopment of streamlined national and institutional cancer registration and data management systemsImprove data collection and management procedures for evidence-based policy and planning
 NationalStrengthen systems for forecasting paediatric cancer drug needsMinimise procurement inefficiencies
Evidence-informed procurement
 National
 Institutional
Implementation of a logistic management systemEnables real-time tracking of institutional tenders, stocks, and prices
Inform procurement and supply management premised on evolving patterns of use and need.
 National
 Institutional
 Community
Increase public awareness of childhood cancer through national health promotional campaignIncrease public awareness
Improve early recognition/diagosis of childhood cancers
Elevate priority of childhood cancers on policy agendas
Investment in Ghana Cancer Board, National Steering Committee for NCDs and relevant stakeholders to advance advocacy for policy reform
Challenge 2: Cancer drug affordability, availability and quality constraints
 InternationalWHO pre-qualification of essential childhood cancer drugsStreamline regulatory processes for importation of quality generic cytotoxic and supportive care drugs for childhood cancer
 National
 Private pharmaceutical
Consolidate existing national pricing control strategies through regulatory reformImprove drug pricing and affordability
Leverage economies of scale across institutions to improve affordability
Increase adherence/minimise treatment abandonment
Decrease taxation on imported drugs
Coordinated public procurement of childhood cancer drugs
Inclusion of childhood cancer in national health insurance scheme benefits package
 NationalExpedited FDA approval processesMinimise stock-outs through decreased order latency and product diversification
Enhance affordability
Generic substitution as a policy directive
  • FDA, Food and Drugs Authority; NCD, non-communicable diseases.